
The reaction uses a catalyst activated with blue LED light.
(Credit: Dr Alex Cresswell)
Scientists at Bath have developed a more sustainable way of making pharmaceuticals that will cut waste and energy usage significantly.
Chemistry researchers at the University of Bath have developed a new method using blue light to create pharmaceuticals in a more sustainable way, significantly reducing the amount of energy needed and the chemical waste created in the manufacture process.
Synthesising small-molecule drugs normally requires several steps, each one creating waste products and solvent waste – these are often toxic and difficult to dispose of safely.
Currently, it is estimated that for every kilogram of drug made, around 100 kg of waste is produced, making it a hugely inefficient process.
The team at Bath, led by Dr Alex Cresswell, a Royal Society University Research Fellow in the University’s Department of Chemistry, has developed a new way of synthesising nitrogen-containing chemicals called primary amines, which are used in more than half of all pharmaceuticals.
The method uses a catalyst, activated by blue light, to speed up the reaction, and uses fewer steps, less energy and dramatically cuts down the waste created by drug development.
The team has tested the method by synthesising a drug used for multiple sclerosis (MS), Fingolimod (brand name Gilenya), which is made by Novartis and had worldwide sales of $3 billion in 2020.
The team has published their research in the Journal of the American Chemical Society (JACS).
Dr Cresswell said: “Making pharmaceuticals can be a wasteful process, with most of that waste being incinerated.
“Our new process synthesises ?-trisubstituted primary amines using only one step, a goal that has eluded chemists for many years.
“People don’t really think about the pharmaceutical industry when it comes to carbon emissions, but some studies have calculated that big pharma emits more than the automotive industry.
“We’re really excited that our group is the first in the world to achieve this breakthrough, and hope that it could in the future lead to much more sustainable pharmaceutical manufacturing processes.
Whilst the new process is not likely to be adopted straight away by pharmaceutical companies for bulk manufacture of existing drugs, the team hopes that the method might speed up the process of discovery and development of new drugs, by making it easier to synthesise new chemical structures for testing.
Dr Cresswell said: “Building new molecules during the drug discovery process requires reactions that make it simple to ‘click’ atoms together in the required way, a bit like building models out of Lego.
“The aim is to make thousands of different derivatives for biological testing, and our new process gives chemists a way to connect certain atoms that simply wasn’t available before. This should help to speed up the discovery process.”
The team is now collaborating with several pharmaceutical companies to scale up the process.
Original Article: Chemistry breakthrough leads way to more sustainable pharmaceuticals
More from: University of Bath
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Pharmaceuticals manufacturing
- Biden looks to boost domestic drug manufacturing amid shortages
Amid widespread drug shortages, President Biden is outlining a plan to increase domestic production of essential pharmaceuticals — including by leveraging a defense law used to bolster countermeasures ...
- Delhi High Court Grants Interim Relief To Sun Pharma In 'Abzorb' Trademark Case
The Delhi High Court has granted interim relief to pharmaceutical giant Sun Pharma in a trademark-infringement case against Delhi-based nutritional ...
- Indian drug manufacturers benefit from Big Pharma interest beyond China
Drugmakers shift reliance from China to India, benefiting Indian CDMOs. Western pharma companies are seeking to limit reliance on Chinese contractors, leading to increased interest in Indian CDMOs.
- Pharma Grade Sodium Bicarbonate Market Expected to Reach US$ 315.4 Million by 2028 with a Healthy 3.5% CAGR
In 2022, sales in the global market for pharma grade sodium bicarbonate are anticipated to reach US$ 256.0 Million. By 2028, the market size is expected to reach US$ 315.4 Million, growing at a robust ...
- Indian pharma manufacturers gain momentum as alternatives to Chinese partners
In a significant industry shift, pharmaceutical companies are actively exploring alternatives to Chinese contractors for drug production, driven by concerns over geopolitical tensions and supply chain ...
Go deeper with Google Headlines on:
Pharmaceuticals manufacturing
[google_news title=”” keyword=”pharmaceuticals manufacturing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Sustainable pharmaceutical manufacturing
- SGD Pharma tailors lightweight glass bottles to beauty and cosmetics products
SGD Pharma has revealed a lightweight glass bottle range that claims to optimize weight, lower carbon footprint, and utilize the functionality and aesthetic appeal of glass in cosmetics and beauty ...
- Future Market Insights Inc. Unveils Mullein Leaf Market’s Sustainable Goals for 2032, Targeting a 3.5% Yearly Expansion Rate
The global market demand for Mullein Leaf is estimated at US$ 3,390 million in 2022, which is forecast to grow at a CAGR of 3.5%, to reach US$ 4,781.6 million between 2022 and 2032 estimated. The ...
- Moderna begins work on China mRNA manufacturing site
U.S. vaccine maker Moderna began construction of its first facility in China this month to manufacture mRNA medicines, the company said on Tuesday. Moderna's COVID-19 vaccine has yet to be approved in ...
- Cadila Pharmaceuticals inaugurates API plant at Dahej in Gujarat’s Bharuch district
Cadila Pharmaceuticals had earlier signed an MoU with the government of Gujarat for investing Rs. 1,000 crore in Gujarat. The Dahej API facility is one of the projects for which the MoU was signed.
- Global Experts Will Gather At Medlab Middle East To Highlight The Importance Of Sustainability In Laboratories
An energy-intensive industry, laboratories consume ten times more power than commercial office spaces Medlab Middle East will un ...
Go deeper with Google Headlines on:
Sustainable pharmaceutical manufacturing
[google_news title=”” keyword=”sustainable pharmaceutical manufacturing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]